AAPL336.67+3.04 (+0.91%) ▲|ABBV271.36+4.67 (+1.75%) ▲|ABT98.73+0.57 (+0.58%) ▲|ACN196.64+3.24 (+1.68%) ▲|ADBE232.77-5.35 (-2.25%) ▼|AMAT520.65-9.62 (-1.81%) ▼|AMD645.86-3.56 (-0.55%) ▼|AMGN413.08+10.48 (+2.60%) ▲|AMT166.18+1.40 (+0.85%) ▲|AMZN259.92+3.63 (+1.42%) ▲|AVGO376.51+0.70 (+0.19%) ▲|AXP304.25-0.30 (-0.10%) ▼|BA188.32-1.50 (-0.79%) ▼|BAC53.52-0.57 (-1.05%) ▼|BKNG155.87-1.76 (-1.12%) ▼|BLK1,069.63-9.79 (-0.91%) ▼|BMY59.70+0.11 (+0.18%) ▲|BNY142.72-1.01 (-0.70%) ▼|BRK-B506.25+0.71 (+0.14%) ▲|C127.32-1.20 (-0.93%) ▼|CAT813.83-49.61 (-5.75%) ▼|CL87.21-0.04 (-0.05%) ▼|CMCSA20.94-0.29 (-1.37%) ▼|COF195.91+0.09 (+0.05%) ▲|COP129.84+0.49 (+0.38%) ▲|COST942.25+6.57 (+0.70%) ▲|CRM224.56-0.43 (-0.19%) ▼|CSCO117.39-0.55 (-0.47%) ▼|CVS87.95+1.52 (+1.76%) ▲|CVX205.15-2.43 (-1.17%) ▼|DE656.87-25.92 (-3.80%) ▼|DHR218.49+2.88 (+1.34%) ▲|DIS104.75+0.72 (+0.69%) ▲|DUK115.50-0.16 (-0.14%) ▼|EMR159.22-2.18 (-1.35%) ▼|FDX289.04+0.01 (+0.00%) ▲|GD326.63-4.70 (-1.42%) ▼|GE303.62-5.77 (-1.87%) ▼|GEV997.09-32.12 (-3.12%) ▼|GILD146.85+2.62 (+1.82%) ▲|GM80.99-1.02 (-1.24%) ▼|GOOG347.37+2.78 (+0.81%) ▲|GOOGL350.50+2.82 (+0.81%) ▲|GS887.21-9.97 (-1.11%) ▼|HD285.77-0.92 (-0.32%) ▼|HON208.11-4.76 (-2.24%) ▼|IBM220.51-0.78 (-0.35%) ▼|INTC113.12+0.62 (+0.55%) ▲|INTU297.24+7.43 (+2.56%) ▲|ISRG414.52+9.76 (+2.41%) ▲|JNJ258.45+3.67 (+1.44%) ▲|JPM329.58-1.70 (-0.51%) ▼|KO85.82-0.35 (-0.41%) ▼|LIN483.98-5.97 (-1.22%) ▼|LLY1,188.72+31.23 (+2.70%) ▲|LMT499.22-10.90 (-2.14%) ▼|LOW181.54-2.13 (-1.16%) ▼|LRCX329.51-4.42 (-1.32%) ▼|MA570.06+3.48 (+0.61%) ▲|MCD230.88-1.57 (-0.68%) ▼|MDLZ59.38-0.24 (-0.40%) ▼|MDT85.51-1.58 (-1.81%) ▼|META721.31-17.57 (-2.38%) ▼|MMM162.12-1.52 (-0.93%) ▼|MO69.38+0.83 (+1.21%) ▲|MRK142.79+0.85 (+0.60%) ▲|MS189.71-1.31 (-0.69%) ▼|MSFT529.76+0.46 (+0.09%) ▲|MU1,088.00+42.44 (+4.06%) ▲|NEE77.06-0.82 (-1.05%) ▼|NFLX69.70+1.01 (+1.47%) ▲|NKE34.36-0.25 (-0.72%) ▼|NOW137.87-0.10 (-0.07%) ▼|NVDA237.47-1.77 (-0.74%) ▼|ORCL143.56-1.21 (-0.84%) ▼|PEP123.73-1.98 (-1.58%) ▼|PFE28.00+0.50 (+1.82%) ▲|PG147.82-0.59 (-0.40%) ▼|PLTR194.12+2.05 (+1.07%) ▲|PM192.69+2.29 (+1.20%) ▲|QCOM177.12-3.91 (-2.16%) ▼|RTX180.26-3.03 (-1.65%) ▼|SBUX93.58-2.53 (-2.63%) ▼|SCHW95.58-1.22 (-1.26%) ▼|SO85.44+0.00 (+0.00%) ▲|SPG197.59-4.15 (-2.06%) ▼|T24.47+0.04 (+0.16%) ▲|TMO662.06+5.48 (+0.83%) ▲|TMUS167.65+1.72 (+1.04%) ▲|TSLA377.81-2.87 (-0.75%) ▼|TXN288.98-8.25 (-2.78%) ▼|UBER68.45-0.63 (-0.91%) ▼|UNH375.98-0.34 (-0.09%) ▼|UNP274.68-1.93 (-0.70%) ▼|UPS92.29-0.82 (-0.88%) ▼|USB56.17-1.12 (-1.96%) ▼|V372.10+1.46 (+0.39%) ▲|VZ45.77-0.21 (-0.46%) ▼|WFC80.26-1.25 (-1.53%) ▼|WMT108.16+0.96 (+0.90%) ▲|XOM164.05-0.43 (-0.26%) ▼|AAPL336.67+3.04 (+0.91%) ▲|ABBV271.36+4.67 (+1.75%) ▲|ABT98.73+0.57 (+0.58%) ▲|ACN196.64+3.24 (+1.68%) ▲|ADBE232.77-5.35 (-2.25%) ▼|AMAT520.65-9.62 (-1.81%) ▼|AMD645.86-3.56 (-0.55%) ▼|AMGN413.08+10.48 (+2.60%) ▲|AMT166.18+1.40 (+0.85%) ▲|AMZN259.92+3.63 (+1.42%) ▲|AVGO376.51+0.70 (+0.19%) ▲|AXP304.25-0.30 (-0.10%) ▼|BA188.32-1.50 (-0.79%) ▼|BAC53.52-0.57 (-1.05%) ▼|BKNG155.87-1.76 (-1.12%) ▼|BLK1,069.63-9.79 (-0.91%) ▼|BMY59.70+0.11 (+0.18%) ▲|BNY142.72-1.01 (-0.70%) ▼|BRK-B506.25+0.71 (+0.14%) ▲|C127.32-1.20 (-0.93%) ▼|CAT813.83-49.61 (-5.75%) ▼|CL87.21-0.04 (-0.05%) ▼|CMCSA20.94-0.29 (-1.37%) ▼|COF195.91+0.09 (+0.05%) ▲|COP129.84+0.49 (+0.38%) ▲|COST942.25+6.57 (+0.70%) ▲|CRM224.56-0.43 (-0.19%) ▼|CSCO117.39-0.55 (-0.47%) ▼|CVS87.95+1.52 (+1.76%) ▲|CVX205.15-2.43 (-1.17%) ▼|DE656.87-25.92 (-3.80%) ▼|DHR218.49+2.88 (+1.34%) ▲|DIS104.75+0.72 (+0.69%) ▲|DUK115.50-0.16 (-0.14%) ▼|EMR159.22-2.18 (-1.35%) ▼|FDX289.04+0.01 (+0.00%) ▲|GD326.63-4.70 (-1.42%) ▼|GE303.62-5.77 (-1.87%) ▼|GEV997.09-32.12 (-3.12%) ▼|GILD146.85+2.62 (+1.82%) ▲|GM80.99-1.02 (-1.24%) ▼|GOOG347.37+2.78 (+0.81%) ▲|GOOGL350.50+2.82 (+0.81%) ▲|GS887.21-9.97 (-1.11%) ▼|HD285.77-0.92 (-0.32%) ▼|HON208.11-4.76 (-2.24%) ▼|IBM220.51-0.78 (-0.35%) ▼|INTC113.12+0.62 (+0.55%) ▲|INTU297.24+7.43 (+2.56%) ▲|ISRG414.52+9.76 (+2.41%) ▲|JNJ258.45+3.67 (+1.44%) ▲|JPM329.58-1.70 (-0.51%) ▼|KO85.82-0.35 (-0.41%) ▼|LIN483.98-5.97 (-1.22%) ▼|LLY1,188.72+31.23 (+2.70%) ▲|LMT499.22-10.90 (-2.14%) ▼|LOW181.54-2.13 (-1.16%) ▼|LRCX329.51-4.42 (-1.32%) ▼|MA570.06+3.48 (+0.61%) ▲|MCD230.88-1.57 (-0.68%) ▼|MDLZ59.38-0.24 (-0.40%) ▼|MDT85.51-1.58 (-1.81%) ▼|META721.31-17.57 (-2.38%) ▼|MMM162.12-1.52 (-0.93%) ▼|MO69.38+0.83 (+1.21%) ▲|MRK142.79+0.85 (+0.60%) ▲|MS189.71-1.31 (-0.69%) ▼|MSFT529.76+0.46 (+0.09%) ▲|MU1,088.00+42.44 (+4.06%) ▲|NEE77.06-0.82 (-1.05%) ▼|NFLX69.70+1.01 (+1.47%) ▲|NKE34.36-0.25 (-0.72%) ▼|NOW137.87-0.10 (-0.07%) ▼|NVDA237.47-1.77 (-0.74%) ▼|ORCL143.56-1.21 (-0.84%) ▼|PEP123.73-1.98 (-1.58%) ▼|PFE28.00+0.50 (+1.82%) ▲|PG147.82-0.59 (-0.40%) ▼|PLTR194.12+2.05 (+1.07%) ▲|PM192.69+2.29 (+1.20%) ▲|QCOM177.12-3.91 (-2.16%) ▼|RTX180.26-3.03 (-1.65%) ▼|SBUX93.58-2.53 (-2.63%) ▼|SCHW95.58-1.22 (-1.26%) ▼|SO85.44+0.00 (+0.00%) ▲|SPG197.59-4.15 (-2.06%) ▼|T24.47+0.04 (+0.16%) ▲|TMO662.06+5.48 (+0.83%) ▲|TMUS167.65+1.72 (+1.04%) ▲|TSLA377.81-2.87 (-0.75%) ▼|TXN288.98-8.25 (-2.78%) ▼|UBER68.45-0.63 (-0.91%) ▼|UNH375.98-0.34 (-0.09%) ▼|UNP274.68-1.93 (-0.70%) ▼|UPS92.29-0.82 (-0.88%) ▼|USB56.17-1.12 (-1.96%) ▼|V372.10+1.46 (+0.39%) ▲|VZ45.77-0.21 (-0.46%) ▼|WFC80.26-1.25 (-1.53%) ▼|WMT108.16+0.96 (+0.90%) ▲|XOM164.05-0.43 (-0.26%) ▼|
14.1 C
New York
Thursday, October 8, 2026

Tag: source

Analysis Group Co-Authors Examine the Advancements in and Application of Health Economics and Outcomes Research to the Evaluation of Cell and Gene Therapies for...

BOSTON, July 22, 2025 /PRNewswire/ -- In a new article published in Value in Health, researchers from Analysis Group, a global leader in health economics...

INVESTOR ALERT: Investigation of Replimune Group, Inc. (REPL) Announced by Holzer & Holzer, LLC

ATLANTA, July 22, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) complied with federal securities laws. On July 22, 2025, Replimune announced it received a Complete Response Letter (“CRL”) from the FDA regarding the Biologics License Application (“BLA”) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of advanced melanoma. In the CRL, the FDA indicated “that the IGNYTE trial is not considered to be an adequate and well-controlled clinical investigation that provides substantial evidence of effectiveness.” Following this news, the price of the Company’s stock dropped. 

Command Alkon Wins 2025 Top Workplaces Industry Award, A National Recognition

BIRMINGHAM, Ala., July 22, 2025 (GLOBE NEWSWIRE) -- Command Alkon, the global leader in software and technology solutions for the heavy building materials industry, has announced today that it is a 2025 Top Workplaces Industry winner, as recognized by Energage, a purpose-driven organization that develops solutions to build and brand Top Workplaces.

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC

Clinical efficacy and safety data will be presented from over 70 small-cell lung cancer (SCLC) patients in Hengrui's ongoing, multi-site, open label Phase 1...

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

Basel, 22 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today its Board of Directors' decision to propose to shareholders a modernisation of Roche Holding Ltd’s capital structure for approval at the Annual General Meeting to be held on 10 March 2026 ("2026 AGM"). The proposal includes the exchange of the existing non-voting equity securities (“Genussscheine”) for participation certificates with a nominal value of CHF 0.001 each.

Transaction in Own Shares

Transaction in Own Shares

Alterra IOS Acquires 12-Property, 43-Acre Industrial Outdoor Storage Portfolio

Acquisition further strengthens firm’s position among the largest national owners of IOS

Ekinops Redefines Optical Network Capacity for Telegraph42 Long-Haul Network

PARIS, July 22, 2025 /PRNewswire/ -- Ekinops (Euronext Paris: EKI) (FR0011466069), a leading optical transport and network access specialist for enterprise-trusted connectivity solutions, today announced that...

Real American Beer Launches in New Jersey With Major Retail + WWE Activation

Real American Beer launches in NJ with ShopRite, WWE’s Jey Uso, and a statewide sweepstakes—now pouring bold energy across the Garden State.

Stardog Appoints Sara Golbourn as Chief Revenue Officer to Scale the Enterprise Answer Engine

Stardog Appoints Sara Golbourn as Chief Revenue Officer to Scale the Enterprise Answer Engine

URBAN SCIENCE AND THE HARRIS POLL RELEASE 2025 AUTOMOTIVE DATA AND INSIGHTS KEY FINDINGS

The gap between dealers' perceived industry momentum and auto-buyers' hesitation widens DETROIT, July 22, 2025 /PRNewswire/ -- Urban Science®, a global automotive consultancy and technology...

Somatus Surpasses 500,000 Patients Actively Under Management Across All 50 States and DC

Value-based kidney care leader expands capabilities in CHF care management, commercial self-insured populations, and AI-driven disease identification and payment integrity services MCLEAN, Va., July 22,...

QNB Corp. Reports Earnings for Second Quarter 2025

QUAKERTOWN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- QNB Corp. (the “Company” or “QNB”) (OTCQX: QNBC), the parent company of QNB Bank (the “Bank”), reported net income for the second quarter of 2025 of $3,883,000 or $1.04 per share on a diluted basis. This compares to net income of $2,465,000, or $0.67 per share on a diluted basis, for the same period in 2024. For the six months ended June 30, 2025, QNB reported net income of $6,461,000, or $1.74 per share on a diluted basis. This compares to net income of $5,059,000, or $1.38 per share on a diluted basis, reported for the same period in 2024.

Adam Breen Joins Accruit as Vice President of Product and Strategy

Accomplished Product and Strategy Executive joins Accruit's Senior Leadership Team to Drive Product Innovation and Advance Technology Strategy DENVER, July 22, 2025 /PRNewswire/ -- Accruit,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSource